Search results for “Hemangioblast” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 136 patents, we discovered top 20 key players by total patent application. Astellas Institute for Regenerative Medicine, Stem Cell & Regenerative Medicine International, Inc., t2cure GmbH are dominant in this area. They take 69.85% of the total patent filing.
Massachusetts, United States
Patent: 69
Massachusetts, United States
Patent: 19
Hessen, Germany
Patent: 5
Hokkaido, Japan
Patent: 5
Germany
Patent: 4
Lombardia, Italy
Patent: 3
Australia
Patent: 2
Massachusetts, United States
Patent: 2
South Korea
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 32 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing Astellas Institute for Regenerative Medicine, The Hospital for Sick Children, Cynata Therapeutics Ltd. take 78.13% of patent filing during this period.
Massachusetts, United States
Patent: 18
The Hospital for Sick Children
Ontario, Canada
Patent: 5
Australia
Patent: 2
Massachusetts, United States
Patent: 2
Madrid, Spain
Patent: 1
Tokyo-to, Japan
Patent: 1
Ontario, Canada
Patent: 1
Illinois, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 32 patents in last 5 years, we discover 5 new entrants. Cynata Therapeutics Ltd., Consejo Superior de Investigaciones Científicas, Keio University are the most active new entrants in this area.
Australia
Patent: 2
Madrid, Spain
Patent: 1
Tokyo-to, Japan
Patent: 1
Ontario, Canada
Patent: 1
Illinois, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 47 patents, we discovered top 11 universities and scientific research institutions by total patent application. Tokai University, National University of Singapore, Agency for Science, Technology & Research are dominant in this area. They take 59.57% of the total patent filing.
Tokyo-to, Japan
Patent: 7
Central Region, Singapore
Patent: 5
Central Region, Singapore
Patent: 5
South Korea
Patent: 3
United States
Patent: 2
New York, United States
Patent: 1
Connecticut, United States
Patent: 1
Tokyo-to, Japan
Patent: 1
France
Patent: 1
Zhejiang Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: